Stockreport

I-MAB Announces Pricing of U.S. Initial Public Offering

I-MAB - American Depositary Shares  (IMAB) 
PDF SHANGHAI, China and ROCKVILLE, Md., Jan. 17, 2020 (GLOBE NEWSWIRE) -- I-Mab (“I-Mab” or the “Company”) (NASDAQ: IMAB), a clinical stage biopharmaceutical company commi [Read more]